Current Vascular Pharmacology

Papers
(The median citation count of Current Vascular Pharmacology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Cardiovascular Disease in Systemic Lupus Erythematosus: Recent Data on Epidemiology, Risk Factors and Prevention59
Herbal Medicine for Slowing Aging and Aging-associated Conditions: Efficacy, Mechanisms and Safety51
Uncaria rhynchophylla and its Major Constituents on Central Nervous System: A Review on Their Pharmacological Actions39
Primary Sjögren’s Syndrome and Cardiovascular Disease26
Lifestyle, Maternal Nutrition and Healthy Pregnancy24
Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports22
Cardiovascular Complications of Sleep Disorders: A Better Night’s Sleep for a Healthier Heart / From Bench to Bedside22
Rhizoma Coptidis for Alzheimer’s Disease and Vascular Dementia: A Literature Review21
Cardiovascular Risk in Rheumatoid Arthritis and Mechanistic Links: From Pathophysiology to Treatment19
Osteoprotegerin and Osteopontin Serum Levels are Associated with Vascular Function and Inflammation in Coronary Artery Disease Patients18
Effects of Maternal Obesity and Gestational Diabetes Mellitus on the Placenta: Current Knowledge and Targets for Therapeutic Interventions18
Endothelial Dysfunction and Inflammatory Markers of Vascular Disease17
Effects of Maternal Obesity On Placental Phenotype15
Vitamin D and Vascular Disease15
The Innate Immune System and Cardiovascular Disease in ESKD: Monocytes and Natural Killer Cells14
Inflammatory Markers in Cardiovascular Disease; Lessons Learned and Future Perspectives14
Pathophysiology of Thrombosis in Peripheral Artery Disease14
Metabolic Adaptations to Pregnancy in Healthy and Gestational Diabetic Pregnancies: The Pancreas - Placenta Axis14
Uric Acid in Metabolic and Cerebrovascular Disorders: A Review13
Coronary Calcium Risk Score and Cardiovascular Risk13
Prevalence, Diagnosis, and Treatment with 3 Different Statins of Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?13
Antipsychotic Drugs and Risk of Developing Venous Thromboembolism and Pulmonary Embolism: A Systematic Review and Meta-Analysis13
Pre- and Post-Conditioning of the Heart: An Overview of Cardioprotective Signaling Pathways13
Antiplatelet Therapy in Acute Coronary Syndromes. Lights and Shadows of Platelet Function Tests to Guide the Best Therapeutic Approach12
Cardiovascular Consequences of Autoimmune Rheumatic Diseases12
New Insight into the Mechanisms of Ginkgo Biloba Extract in Vascular Aging Prevention12
LncRNA MALAT1 Enhances ox-LDL-Induced Autophagy through the SIRT1/MAPK/NF-κB Pathway in Macrophages12
The Burden of Cardiovascular Disease Risk Factors in the Middle East: A Systematic Review and Meta-Analysis Focusing on Primary Prevention11
The Endothelial Glycocalyx as a Key Mediator of Albumin Handling and the Development of Diabetic Nephropathy11
PCSK9 Inhibitors and Ezetimibe Monotherapy in Patients Not Receiving Statins: A Meta-Analysis of Randomized Trials11
Efficacy and Safety of Antiplatelet Therapies in Symptomatic Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis11
Diabetes Mellitus, Arterial Stiffness and Cardiovascular Disease: Clinical Implications and the Influence of SGLT2i10
Obesity and Gestational Diabetes in Pregnant Care and Clinical Practice10
Pathogenic Mechanisms of Trimethylamine N-Oxide-induced Atherosclerosis and Cardiomyopathy9
Cardiovascular Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs)9
Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Obstructive Sleep Apnoea Syndrome and Overlap Syndrome9
Non-Alcoholic Fatty Liver Disease and Vascular Disease9
Increased Fetal Cardiovascular Disease Risk: Potential Synergy Between Gestational Diabetes Mellitus and Maternal Hypercholesterolemia9
New Insights into the Role of FGF-23 and Klotho in Cardiovascular Disease in Chronic Kidney Disease Patients9
Inhibition of miR-223 Expression Using a Sponge Strategy Decreases Restenosis in Rat Injured Carotids8
Cardiovascular Disease in Spondyloarthritides8
Erectile Dysfunction as a Cardiovascular Risk Factor: Time to Step Up?8
Improving Adherence to Ticagrelor in Patients After Acute Coronary Syndrome: Results from the PROGRESS Trial8
The Myometrium in Pregnant Women with Obesity8
Pulse Wave Velocity Assessment for Cardiovascular Risk Prognostication in ESKD: Weighting Recent Evidence7
Outcomes of Anticoagulant Therapy with Low-Molecular-Weight Heparin (LMWH) and Warfarin for Thromboangiitis Obliterans (TAO)7
Could Antioxidant Supplementation Delay Progression of Cardiovascular Disease in End-Stage Renal Disease Patients?7
Compelling Indications Should be Listed for Individual Beta-Blockers (Due to Diversity), Not for the Whole Class7
Vitamin K for the Treatment of Cardiovascular Disease in End-Stage Renal Disease Patients: Is there Hope?7
Complementary and Alternative Medicine for the Treatment of Insomnia: An Overview of Scientific Evidence from 2008 to 20187
Non-alcoholic Fatty Liver Disease in Children7
Antithrombotic Therapy in Lower Extremity Artery Disease7
Hypertriglyceridemia: An Infrequent, Difficult-to-predict, Severe Metabolic and Vascular Problem Associated with Estrogen Administration7
Investigating the Link between Psoriasis and Cardiovascular Disease: Current Evidence, Therapeutic Implications and Perspectives6
Metabolic Complications and Kidney Transplantation: Focus on Glycaemia and Dyslipidaemia6
Validation of Neuropad in the Assessment of Peripheral Diabetic Neuropathy in Patients with Diabetes Mellitus Versus the Michigan Neuropathy Screening Instrument, 10g Monofilament Application and Biot6
Contrast-induced Nephropathy in Non-cardiac Vascular Procedures, A Narrative Review: Part 16
Male Patients with Takayasu Arteritis and Coronary Artery Involvement are Prone to Have Serious Coronary Stenosis and High Mortality6
Cardiovascular Disease in the Systemic Vasculitides6
Effect of Mineralocorticoid Receptor Antagonists in Heart Failure with Preserved Ejection Fraction and with Reduced Ejection Fraction - A Narrative Review5
Herbal Medicine for Vascular Dementia: An Overview of Systematic Reviews5
The Role of Inflammation as a Preponderant Risk Factor in Cardiovascular Diseases5
Intermittent Fasting as Possible Treatment for Heart Failure5
Cardiovascular Disease in Antiphospholipid Syndrome5
Prognostic Significance of Relative Hyperglycemia after Percutaneous Coronary Intervention in Patients with and without Recognized Diabetes5
Cardiovascular Disease in Juvenile Idiopathic Arthritis5
Effects of Gentiana lutea Root on Vascular Diseases5
Advanced Glycation End Products in Chinese Medicine Mediated Aging Diseases: A Review5
Epicardial Adipocyte-derived TNF-α Modulates Local Inflammation in Patients with Advanced Coronary Artery Disease4
STOPP/START Anti-aggregation and Anticoagulation Alerts in Atrial Fibrillation4
Contrast-induced Nephropathy in Non-cardiac Vascular Procedures, A Narrative Review: Part 24
Interleukin-10 in the Vasculature: Pathophysiological Implications4
Stromal Cell-Derived Factor (SDF) 2 and the Endoplasmic Reticulum Stress Response of Trophoblast Cells in Gestational Diabetes Mellitus and In vitro Hyperglycaemic Condition4
Association of PAF and its Metabolic Enzymes with GGT and the Fatty Liver Index in Healthy Volunteers4
Comparison of Postprandial Serum Triglyceride and Apolipoprotein B Concentrations between the Two Phases of Menstrual Cycle in Healthy Women4
Negatively-charged Liposome Nanoparticles Can Prevent Dyslipidemia and Atherosclerosis Progression in the Rabbit Model4
Cardiovascular Risk of Synthetic, Non-Biologic Disease-Modifying Anti- Rheumatic Drugs (DMARDs)4
Abnormal Peri-organ-Intra-organ Fat (APIFat) and Rheumatoid Arthritis: An Under-investigated Link for Increased Cardiovascular Risk?4
Cardiovascular Benefits of Extended-Time Nocturnal Hemodialysis4
Vitamin K Supplementation in Chronic Kidney Disease Patients: Where is the Evidence?4
COVID-19-associated Coagulopathy and Thromboembolism: Determination of Their Patterns and Risk Factors as Predictors of Mortality Among Severe COVID-19 Patients4
Cardiovascular Risk and Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients on Therapy With Tolvaptan: A Pilot Study4
Features of a Balanced Healthy Diet with Cardiovascular and Other Benefits4
Current Insights on the Role of Irisin in Endothelial Dysfunction3
Inflammasomes in the Pathophysiology of Maternal Obesity: Potential Therapeutic Targets to Reduce Long-Term Adverse Health Outcomes in the Mother and Offspring3
Exosomes and Exosomal microRNAs in Age-associated Stroke3
Role of Nicotinic Acetylcholine Receptors in Cardiovascular Physiology and Pathophysiology: Current Trends and Perspectives3
Epicardial Adipocyte-derived TNF-α Modulates Local Inflammation in Patients with Advanced Coronary Artery Disease3
Management and Outcomes of Aortic Dissection in Pregnancy with Marfan Syndrome: A Systematic Review3
Arterial Stiffness, Cognitive Dysfunction and Adherence to Antihypertensive Agents. Is there a Link to Hypertensive Patients?3
Have We Learnt all from IMPROVE-IT? Part II. Subanalyses of the Effects of Ezetimibe Added to Statin Therapy on Selected Clinical and Laboratory Outcomes, Cost-Effectiveness, Guidelines, and Clinical 3
The Neuro-Vascular Consequence of Diabetes: Foot Amputation and Evaluation of its Risk Factors and Health-Related Economic Impact3
By Discontinuing Beta-Blockers Before an Exercise Test, We may Precipitate a Rebound Phenomenon3
Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target?3
Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases3
Efficacy and Safety of Evolocumab in Reducing Low-Density Lipoprotein Cholesterol Levels in Chinese Patients with Non-ST-segment Elevation Acute Coronary Syndrome3
Endocrine Disorders and Peripheral Arterial Disease: A Series of Reviews3
Fetal/Infant Origins of Adult Vascular Disease3
Assessment and Management of Volume Overload Among Patients on Chronic Dialysis3
Cardioprotective Effects of Natural Products via the Nrf2 Signaling Pathway3
COVID-19 and Inflammatory Markers3
Contribution of STIM-Activated TRPC-ORAI Channels in Pulmonary Hypertension Induced by Chronic Sustained and Intermittent Hypoxia2
The Recent Trends in All-cause and Cardiovascular Mortality among People with Type 1 Diabetes Mellitus - Success is Still Far Away, and We Must Do Better!2
Gout Flares and Intercritical Gout: Do they Play a Significant Role in Predicting Cardiovascular Events?2
Efficacy and Safety of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus After Acute Anterior Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Intervention2
COVID-19 and Kidney Disease: A Clinical Perspective2
Selenium, Selenoproteins and 10-year Cardiovascular Risk: Results from the ATTICA Study2
Antithrombotic Therapy for Peripheral Revascularisation2
Cilofexor for the Treatment of Nonalcoholic Steatohepatitis2
Effect of Gestational Diabetes Mellitus and Hypercholesterolemia on Fetal Cardiovascular Disease Risk: The Role of Epigenetics2
Rationale and Design of the ACS-BP Study: Prognostic Value of In-Hospital Blood Pressure and Indices of Atherosclerosis in Acute Coronary Syndromes2
The Emerging Role of CircRNAs in Atherosclerosis2
The cGAS-STING Pathway: A Ubiquitous Checkpoint Perturbing Myocardial Attributes2
Epigenetic Changes as a Possible Mechanism Leading to Increased Fetal Cardiovascular Disease Risk in Pregnancies with Gestational Diabetes Mellitus and/or Maternal Hypercholesterolemia2
Antihypertensive Therapy in Patients Receiving Maintenance Hemodialysis: A Narrative Review of the Available Clinical-Trial Evidence2
Arterial Stiffness as a Cardiovascular Risk Factor for the Development of Preeclampsia and Pharmacopreventive Options2
Editorial on Prevalence, Diagnosis and Treatment with 3 Different Statins of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?2
Preliminary Study of the Distinctive Mechanism of Shenqi Compound in Treating Rats with Type 2 Diabetes Mellitus by Comparing with Metformin2
Current Choice for LDL-C Lowering in High-Risk CVD Patients Intolerant to Statins2
Inclisiran. A New Kid on the New Block for Treating Hypercholesterolaemia2
Have We Learnt all from IMPROVE-IT? Part I. Core Results and Subanalyses on the Effects of Ezetimibe Added to Statin Therapy Related to Age, Gender and Selected Chronic Diseases (Kidney Disease, Diabe2
Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiac Structural and Electrical Remodeling: From Myocardial Cytology to Cardiodiabetology2
The Impact of Various Blood Pressure Measurements on Cardiovascular Outcomes1
Paget’s Disease of Bone and Cardiovascular Risk: A Pilot Study1
Cardiac and Vascular Impairment in Patients with Mild Psoriasis: A Longitudinal Study1
New Antithrombotic Strategies and Coronary Stent Technologies for Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention1
Aortic Intima-Media Thickness is Increased in Neonates of Mothers with Gestational Diabetes Mellitus: The Role of Thioredoxin-Interacting Protein as a Marker of Oxidative Stress1
Combination Therapy with Ezetimibe: An Alternative Strategy to Statin Monotherapy in the Management of Patients with Non-cardiac Vascular Disease1
Identification of Novel and Known LDLR Variants Triggering Severe Familial Hypercholesterolemia in Saudi Families1
Cardiometabolic Risk, Peripheral Arterial Disease and Cardiovascular Events in Polycystic Ovary Syndrome: Time to Implement Systematic Screening and Update the Management1
Role of Glycine and Glycine Receptors in Vascular Endothelium: A New Perspective for the Management of the Post-Ischemic Injury1
MDMB-FUBINACA Influences Brain Angiogenesis and the Expression of VEGF, ANG-1, and ANG-21
Inflammation and LDL Reduction1
The Bleeding Risk in Antithrombotic Therapies: A Narrative Review1
Diabetic Cardiomyopathy: Clinical and Metabolic Approach1
Acetylsalicylic Acid (Aspirin) for Primary Prevention of Cardiovascular Events in Patients with Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials1
Diabetes and Obesity in Pregnancy: From Patients to Molecular Mechanisms1
Association Between Telomere Length and Cardiovascular Risk: Pharmacological Treatments Affecting Telomeres and Telomerase Activity1
Patients with Polyvascular Disease: A Very High-risk Group1
Comparison of Efficacy and Safety between Thrombolysis Plus Anticoagulation vs. Anticoagulation Alone for the Treatment of Acute Submassive Pulmonary Embolism: A Systematic Review and Meta-analysis1
Beta-Blockers and Cardiovascular Outcomes in Acute Heart Failure with a History of Coronary Artery Disease and an Ejection Fraction ≥ 40%1
Herbal Medicine for Slowing Aging and Cardiovascular Risk: Mechanisms and Safety1
Ezetimibe and Insulin Resistance1
Contrast-Induced Nephropathy after Endovascular Aneurysm Repair, Carotid and Peripheral Interventions1
Diet and Sudden Death: How to Reduce the Risk1
Mechanisms of Endothelial Dysfunction and Cardiovascular System Adaptation1
Effects of Pregnancy-induced Insulin Resistance on the Fetus and the Future Development of Metabolic Diseases in Adulthood1
Protective or Inhibitory Effect of Pharmacological Therapy on Cardiac Ischemic Preconditioning: A Literature Review1
A Narrative Review of Recent Studies on the Role of Vitamin D in the Prevention of Cardiac and Renal Risk and Additional Considerations for COVID-19 Vulnerability1
Novel Therapeutic Strategies for Cardiorenal Protection in Patients with Type 2 Diabetes and Chronic Kidney Disease1
Hypertension-Mediated Organ Damage In Young Patients With First-Diagnosed And Never Treated Systolic Hypertension1
Varicocele at High Altitude; Venous Outflow Restriction by Hypobaric Hypoxia1
The Relation Between Red Blood Cell Distribution Width and Coronary Atherosclerotic Plaque Vulnerability Detected by Intracoronary Optical Coherence Tomography1
Imbalance of Pro- and Anti-inflammatory Cytokines Induced Different Types of Recurrent Atrial Arrhythmias after Drug Eluting Coronary Stent Implantation1
The Prospect of Genomic, Transcriptomic, Epigenetic and Metabolomic Biomarkers for The Personalized Prevention of Type 2 Diabetes and Cardiovascular Diseases1
Pharmacy and Exercise as Complimentary Partners for Successful Cardiovascular Ageing1
The Fundamental Role of Stress Echo in Evaluating Coronary Artery Disease in Specific Patient Populations1
Management of Dyslipidaemia for the Prevention of Stroke: Clinical Practice Recommendations from the Lipid Association of India1
Evaluation of Therapeutic Agents Targeting the Pathogenesis of Coronary Artery Spasm: A Mini Review1
0.045420169830322